We tested the effects of CC‐115 and SMG1i on various human cancer cell lines, focusing on hematological malignancies, as Kinome‐wide RNAi studies included SMG1 in a list of active kinases in MM models [27]. The gene discussed is SMG1; the disease is Miyoshi myopathy.